Kirsten rat sarcoma viral oncogene (KRAS) G12D and pan-RAS inhibitors in pancreatic ductal adenocarcinoma: clinical progress and strategies to overcome resistance

Cancer Pathogenesis and Therapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles